Tower Research Capital (TRC)’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-29,967
| Closed | -$2K | – | 6760 |
|
2022
Q4 | $2K | Sell |
29,967
-979
| -3% | -$65 | ﹤0.01% | 5521 |
|
2022
Q3 | $4K | Buy |
30,946
+7,125
| +30% | +$921 | ﹤0.01% | 5344 |
|
2022
Q2 | $7K | Buy |
+23,821
| New | +$7K | ﹤0.01% | 4872 |
|
2021
Q4 | – | Sell |
-13,891
| Closed | -$32K | – | 6869 |
|
2021
Q3 | $32K | Buy |
+13,891
| New | +$32K | ﹤0.01% | 3336 |
|
2020
Q3 | – | Sell |
-142
| Closed | – | – | 5225 |
|
2020
Q2 | $0 | Buy |
+142
| New | – | ﹤0.01% | 5093 |
|
2016
Q4 | – | Sell |
-599
| Closed | -$1K | – | 4577 |
|
2016
Q3 | $1K | Buy |
+599
| New | +$1K | ﹤0.01% | 3420 |
|
2016
Q2 | – | Sell |
-1,114
| Closed | -$3K | – | 5176 |
|
2016
Q1 | $3K | Buy |
1,114
+1,014
| +1,014% | +$2.73K | ﹤0.01% | 3197 |
|
2015
Q4 | $0 | Buy |
+100
| New | – | ﹤0.01% | 5252 |
|
2015
Q2 | – | Sell |
-467
| Closed | -$1K | – | 5260 |
|
2015
Q1 | $1K | Buy |
+467
| New | +$1K | ﹤0.01% | 4187 |
|
2013
Q4 | – | Sell |
-255
| Closed | -$8K | – | 5033 |
|
2013
Q3 | $8K | Buy |
+255
| New | +$8K | ﹤0.01% | 3382 |
|